Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.87
NASDAQLPCN
Open
$4.70
Change
$0.19 (4.06%)
Day's Range
$4.70 - $5.00
52-Week Range
$2.44 - $11.79
Volume
65.6K
Market Cap
$26.0M
Currency in USD.
Quote data delayed by at least 15 minutes.